4-Year Results: Tislelizumab Plus Chemo for Esophageal Cancer
In a groundbreaking development within the arena of oncology, new data emerging from the phase 2 TD-NICE clinical trial reveals ...
In a groundbreaking development within the arena of oncology, new data emerging from the phase 2 TD-NICE clinical trial reveals ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine